drugset / Trial / NCT00174200

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

NCT00174200

Completed 20 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

To assess the effect of risperidone 2 mg daily (QD) on the differential sensitivity of 2 spatial working memory tests (the GMLT and MDR) in non-agitated, drug-naive patients suffering from first-episode schizophrenia/schizophreniform disorder.

Timeline

Start
2004-12
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 2 mg

Indications